Extremity Trauma and Regenerative Medicine Task Area, United States Army Institute of Surgical Research, Fort Sam Houston, Texas, USA.
Clin Transl Sci. 2018 Mar;11(2):208-217. doi: 10.1111/cts.12519. Epub 2017 Nov 28.
Volumetric muscle loss (VML) injuries present chronic loss of muscle fibers followed by expansive fibrotic tissue deposition. Regenerative medicine therapies are under development to promote regeneration. However, mitigation of the expansive fibrous tissue is required for integration with the remaining muscle. Using a porcine VML model, delayed debridement of injury fibrosis was performed 3 months post-VML and observed for an additional 4 weeks. A second group underwent the initial VML and was observed for 4 weeks, allowing comparison of initial fibrosis formation and debrided groups. The following salient observations were made: (i) debridement neither exacerbated nor ameliorated strength deficits; (ii) debridement results in recurrent fibrotic tissue deposition of a similar magnitude and composition as acute VML injury; and (iii) similarly upregulated transcriptional fibrotic and transcriptional pathways persist 4 weeks after initial VML or delayed debridement. This highlights the need for future studies to investigate adjunctive antifibrotic treatments for the fibrosed musculature.
体积性肌肉损失 (VML) 损伤表现为肌肉纤维的慢性损失,随后是广泛的纤维组织沉积。正在开发再生医学疗法以促进再生。然而,为了与剩余的肌肉整合,需要减轻扩张性纤维组织。使用猪 VML 模型,在 VML 后 3 个月进行延迟性清创以去除损伤纤维化,并额外观察 4 周。第二组进行初始 VML 并观察 4 周,以比较初始纤维化形成和清创组。观察到以下明显结果:(i) 清创既没有加重也没有改善肌力缺陷;(ii) 清创导致类似急性 VML 损伤的纤维组织反复沉积;和 (iii) 初始 VML 或延迟清创 4 周后,转录纤维化和转录途径仍保持上调。这凸显了未来研究需要调查纤维肌肉的辅助抗纤维化治疗的必要性。